CYP2D6

GENERAL INFORMATION

? »

Gene name

CYP2D6

Gene description

Cytochrome P450, family 2, subfamily D, polypeptide 6

Protein class

Enzymes
Predicted intracellular proteins
Predicted membrane proteins

Predicted localization

Intracellular,Membrane

Number of transcripts

3
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

? »

RNA tissue category

HPA:Group enriched (duodenum, liver, small intestine)
GTEx:Tissue enriched (liver)

Protein evidence

Evidence at protein level

Protein localization

High cytoplasmic expression in liver and small intestine.

ANTIBODY RELIABILITY

? »

Data reliability
description

Antibody staining mainly consistent with RNA expression data. Presumed off target binding observed and disregarded.

Data reliability

Supportive based on 1 antibody.
HPA045223
SHOW MORE

RNA AND PROTEIN EXPRESSION SUMMARY

? »
RNA expression (FPKM) Protein expression (score)
Brain
Endocrine tissues
Bone marrow & immune system
Muscle tissues
Lung
Liver & gallbladder
Pancreas
Gastrointestinal tract
Kidney & urinary bladder
Male tissues
Female tissues
Adipose & soft tissue
Skin
Cerebral cortex

Lymph node

Liver

Colon

Kidney

Testis



PROTEIN EXPRESSION OVERVIEW

? »

Organ

Expression



RNA EXPRESSION OVERVIEW

? »
HPA dataset
RNA tissue category:  Group enriched (duodenum, liver, small intestine)

Organ

Expression

GTEx dataset
RNA tissue category:  Tissue enriched (liver)

Organ

Expression



GENE INFORMATION

? »

Gene name

CYP2D6 (HGNC Symbol)

Synonyms

CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D

Description

Cytochrome P450, family 2, subfamily D, polypeptide 6 (HGNC Symbol)

Entrez gene summary

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]

Chromosome

22

Cytoband

q13.2

Chromosome location (bp)

42126499 - 42130906

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000100197 (version 78.38)

Entrez gene

1565

UniProt

P10635 (UniProt - Evidence at protein level)

neXtProt

NX_P10635

Antibodypedia

CYP2D6 antibodies


PROTEIN BROWSER

? »
 
 
 
ENST00000359033
 
ENST00000360608
 
ENST00000389970
 
 
 
 


PROTEIN INFORMATION

? »

Splice variant

Ensembl

UniProt

Protein class

Gene ontology

Length
(aa)

Molecular mass
(kDa)

Signal peptide
(predicted)

Transmembrane regions
(predicted)

CYP2D6-001 ENSP00000353820
ENST00000360608
P10635
Show all »
Show » Show » 497 55.8 No 2
CYP2D6-002 ENSP00000351927
ENST00000359033
P10635
Show all »
Show » Show » 446 50.1 No 2
CYP2D6-201 ENSP00000374620
ENST00000389970
Show » Show » 494 55.2 No 0